1. Combinational treatments of RNA interference and extracellular vesicles in the spinocerebellar ataxia
    Yingying Ding et al, 2022, Frontiers in Molecular Neuroscience CrossRef
  2. Association of Insulin-like Growth Factor-1 and Neurofilament Light Chain in Patients with Progressive Supranuclear Palsy
    Saikat Dey et al, 2024, Annals of Indian Academy of Neurology CrossRef
  3. MicroRNA as Candidate Biomarkers in Atypical Parkinsonian Syndromes: Systematic Literature Review
    Anastasia Bougea, 2022, Medicina CrossRef
  4. Plasma microRNAs as a Potential Biomarker for Identification of Progressive Supranuclear Palsy
    Palaniswamy Ramaswamy et al, 2022, Diagnostics CrossRef
  5. microRNA and circRNA in Parkinson’s Disease and atypical parkinsonian syndromes
    Anastasia Bougea et al, 2023, Advances In Clinical Chemistry CrossRef
  6. Circulating miRNAs in progressive supranuclear palsy: Recent evidence and future challenges
    Ida Manna et al, 2022, Parkinsonism & Related Disorders CrossRef
  7. Dysregulated miRNAs as Biomarkers and Therapeutical Targets in Neurodegenerative Diseases
    Giulia Gentile et al, 2022, Journal of Personalized Medicine CrossRef
  8. Potential of Non-Coding RNA as Biomarkers for Progressive Supranuclear Palsy
    Fabio A. Simoes et al, 2022, International Journal of Molecular Sciences CrossRef
  9. Deciphering the role of precursor miR-12136 and miR-8485 in the progression of intellectual disability (ID)
    Prekshi Garg et al, 2022, IBRO Neuroscience Reports CrossRef
  10. Metabolites and Biomarker Compounds of Neurodegenerative Diseases in Cerebrospinal Fluid
    Keiji Wakamatsu et al, 2022, Metabolites CrossRef
  11. Age‑related brainstem degeneration through microRNA modulation in mice
    Rie Kawakita et al, 2023, Molecular Medicine Reports CrossRef